Eyestem Research secures $10M in Series B funding

Eyestem Research, a Bengaluru biotech, raised $10M in Series B funding co-led by Raju Barwale and Alkem’s Sandeep Singh. The funds will back Phase 2 trials in India and an IND application to the US FDA. Founded by Jogin Desai, Rajani Battu, and Rajarshi Pal, Eyestem develops cell therapies for eye diseases like dry AMD. Its Eyecyte-RPE therapy replaces damaged retinal cells; Phase 1 data awaits CDSCO Phase 2 clearance.